BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 9802273)

  • 1. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
    Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R
    Lancet; 1998 Oct; 352(9137):1347-51. PubMed ID: 9802273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study].
    Seux ML; Staessen JA; Forette F
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1083-7. PubMed ID: 10486670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
    Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].
    Seux ML; Thijs L; Forette F
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1169-72. PubMed ID: 9404430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
    Staessen J; Amery A; Birkenhäger W; Bulpitt CJ; Cox J; de Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):120-5. PubMed ID: 1375678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
    Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive treatment and prevention of dementia].
    Seux ML
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):512-7. PubMed ID: 12555375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
    Peters R; Beckett N; Forette F; Tuomilehto J; Clarke R; Ritchie C; Waldman A; Walton I; Poulter R; Ma S; Comsa M; Burch L; Fletcher A; Bulpitt C;
    Lancet Neurol; 2008 Aug; 7(8):683-9. PubMed ID: 18614402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
    J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
    Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
    Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.
    McGuinness B; Todd S; Passmore P; Bullock R
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004034. PubMed ID: 16625595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.
    Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH
    Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.
    McGuinness B; Todd S; Passmore P; Bullock R
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004034. PubMed ID: 19821318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial.
    Hara A; Thijs L; Asayama K; Jacobs L; Wang JG; Staessen JA
    PLoS One; 2014; 9(8):e103169. PubMed ID: 25090617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Fagard RH; Staessen JA
    Clin Exp Hypertens; 1999; 21(5-6):491-7. PubMed ID: 10423075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
    Hall WD
    Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijisq L; Fagard R; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A;
    J Hypertens; 2004 Apr; 22(4):847-57. PubMed ID: 15126928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.
    Peters R; Beckett N; Nunes M; Fletcher A; Forette F; Bulpitt C
    Drugs Aging; 2006; 23(1):83-92. PubMed ID: 16492072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.